Rat TAFI(Thrombin Activatable Fibrinolysis Inhibitor) ELISA Kit

3h

50ng/mL

Sandwich

0.33ng/mL

0.781-50ng/mL

Rattus norvegicus

Metabolic pathway;Hematology;

ELISA Enzyme-linked immunosorbent assays Code 90320007 SNOMED

CPB2; CPU; PCPB; Carboxypeptidase B2; Plasma Carboxypeptidase B; Carboxypeptidase U

E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays,E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays

Rats are used to make rat monoclonal anti mouse antibodies. There are less rat- than mouse clones however. Rats genes from rodents of the genus Rattus norvegicus are often studied in vivo as a model of human genes in Sprague-Dawley or Wistar rats.

Tissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.

The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Thrombin Activatable Fibrinolysis Inhibitor (TAFI). Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody specific to Thrombin Activatable Fibrinolysis Inhibitor (TAFI). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Thrombin Activatable Fibrinolysis Inhibitor (TAFI), biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Thrombin Activatable Fibrinolysis Inhibitor (TAFI) in the samples is then determined by comparing the O.D. of the samples to the standard curve.